FDA clarifies its approach to biotech animals

The Food and Drug Administration, the lead U.S. regulator of genetically engineered animals, issued two documents to clarify its risk-based oversight of the creatures and their developers. The agency exercises varying levels of scrutiny, ranging from full-scale review of an animal and its risk profile to instances in which developers can take an animal directly… » Read More

The Ag Insider content is only available to members.